Compugen reported $954K in Interest Expense on Debt for its fiscal quarter ending in September of 2025.





Interest Expense On Debt Change Date
Arca Biopharma USD 504K 246K Sep/2024
aTyr Pharma 79.65M 78.89M Mar/2026
Bio Path 130K 95K Sep/2025
Cara Therapeutics -89.64M 128.67M Dec/2025
Compugen USD 954K 116K Sep/2025
Immunic 197K 222K Dec/2025
Infinity Pharmaceuticals USD 45K 0 Jun/2023
Minerva Neurosciences USD 2.31M 60K Jun/2024
RedHill Biopharma USD 89.8K 31.69M Jun/2024
TherapeuticsMD USD 20K 25K Sep/2023